Výsledky vyhledávání - Michael Peyton
- Zobrazuji výsledky 1 - 20 z 43
- Přejít na další stránku
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner Autor Robin E. Frink, Michael Peyton, Joan H. Schiller, Adi F. Gazdar, Jerry W. Shay, John D. Minna
Vydáno 2016Artigo -
8
Distinct transcriptome profiles identified in normal human bronchial epithelial cells after exposure to γ-rays and different elemental particles of high Z and energy Autor Liang-Hao Ding, Seong‐Mi Park, Michael Peyton, Luc Girard, Yang Xie, John D. Minna, Michael D. Story
Vydáno 2013Artigo -
9
-
10
-
11
-
12
-
13
On the molecular basis and regulation of cellular capacitative calcium entry: Roles for Trp proteins Autor Lutz Birnbaumer, Xiangcheng Zhu, Meisheng Jiang, Guylain Boulay, Michael Peyton, Brigitte Vannier, Darren L. Brown, Daniela Platano, M. Hamid, Enrico Stefani, Mariel Birnbaumer
Vydáno 1996Revisão -
14
Non–Small Cell Lung Cancers with Kinase Domain Mutations in the Epidermal Growth Factor Receptor Are Sensitive to Ionizing Radiation Autor Amit Kumar Das, Mitsuo Sato, Michael D. Story, Michael Peyton, Robert J. Graves, Stella Redpath, Luc Girard, Adi F. Gazdar, Jerry W. Shay, John D. Minna, Chaitanya S. Nirodi
Vydáno 2006Artigo -
15
SMAC Mimetic (JP1201) Sensitizes Non–Small Cell Lung Cancers to Multiple Chemotherapy Agents in an IAP-Dependent but TNF-α–Independent Manner Autor Rachel M. Greer, Michael Peyton, Jill E. Larsen, Luc Girard, Yang Xie, Adi F. Gazdar, Patrick G. Harran, Lai Wang, Rolf A. Brekken, Xiaodong Wang, John D. Minna
Vydáno 2011Artigo -
16
Combination Treatment with MEK and AKT Inhibitors Is More Effective than Each Drug Alone in Human Non-Small Cell Lung Cancer In Vitro and In Vivo Autor Jieru Meng, Bingbing Dai, Bingliang Fang, B. Nebiyou Bekele, William G. Bornmann, Duoli Sun, Zhenghong Peng, Roy S. Herbst, Vassiliki A. Papadimitrakopoulou, John D. Minna, Michael Peyton, Jack A. Roth
Vydáno 2010Artigo -
17
Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy Autor Noriaki Sunaga, David S. Shames, Luc Girard, Michael Peyton, Jill E. Larsen, Hisao Imai, Junichi Soh, Mitsuo Sato, Noriko Yanagitani, Kyoichi Kaira, Yang Xie, Adi F. Gazdar, Masatomo Mori, John D. Minna
Vydáno 2011Artigo -
18
Alterations in Genes of the EGFR Signaling Pathway and Their Relationship to EGFR Tyrosine Kinase Inhibitor Sensitivity in Lung Cancer Cell Lines Autor Jeet Gandhi, Jianling Zhang, Yang Xie, Junichi Soh, Hisayuki Shigematsu, Wei Zhang, Hiromasa Yamamoto, Michael Peyton, Luc Girard, William W. Lockwood, Wan L. Lam, Marileila Varella‐Garcia, John D. Minna, Adi F. Gazdar
Vydáno 2009Artigo -
19
EGFR-Mediated Beclin 1 Phosphorylation in Autophagy Suppression, Tumor Progression, and Tumor Chemoresistance Autor Yongjie Wei, Zhongju Zou, Nils Becker, Matthew Anderson, Rhea Sumpter, Guanghua Xiao, Lisa N. Kinch, Prasad Koduru, Christhunesa S. Christudass, Robert W. Veltri, Nick V. Grishin, Michael Peyton, John D. Minna, Govind Bhagat, Beth Levine
Vydáno 2013Artigo -
20
SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers Autor Vural Tagal, Shuguang Wei, Wei Zhang, Rolf A. Brekken, Bruce A. Posner, Michael Peyton, Luc Girard, TaeHyun Hwang, David A. Wheeler, John D. Minna, Michael A. White, Adi F. Gazdar, Michael G. Roth
Vydáno 2017Artigo
Vyhledávací nástroje:
Související témata
Biology
Cancer research
Medicine
Cancer
Gene
Genetics
Internal medicine
Lung cancer
Biochemistry
Cell biology
Signal transduction
Epidermal growth factor receptor
Oncology
Receptor
Chemistry
Erlotinib
KRAS
Cell culture
Gefitinib
Gene expression
Apoptosis
EGFR inhibitors
Pathology
Tyrosine kinase
Colorectal cancer
Computational biology
Immunology
Molecular biology
Mutant
Cancer cell